Search results
Author(s):
Atul Verma
Added:
1 year ago
ACC.23/WCC - Principal Investigator, DrAtul Verma (McGill University Health Centre, CA) joins us on-site at ACC's 2023 Scientific Sessions to outline the findings of the PULSED-AF Trial(Medtronic Cardiac Rhythm and Heart Failure) (NCT04198701).
In this prospective, multicenter study, 421 patients with persistent atrial fibrillation (AF) were treated with the Medtronic PulseSelect Pulsed Field…
View more
Author(s):
George D Katritsis
,
Demosthenes G Katritsis
Added:
3 years ago
Implantable cardiac devices, such as pacemakers, are used to treat a number of heart conditions, especially those related to the electrical conduction system. Cardiac pacemakers are a well-established and effective therapy, and have been in use for more than 50 years.
The first pacemaker was implanted in a patient in October 1958 by Åke Senning in Stockholm, in cooperation with engineer Rune…
View more
Author(s):
Atul Verma
Added:
3 years ago
Dr Atul Verma (Southlake Regional Health Center, Toronto, ON, CA) on behalf of the PULSED AF Investigators shares the results of a study measuring the safety and effectiveness of the novel Pulsed Field Ablation (PFA) technology.
Dr Verma tells us about the difference between Pulsed Field Ablation (PFA) and Point-to-Point pulsed ablations and talks about the future plans for this technology.
…
View more
Author(s):
Tobias Reichlin
Added:
7 months ago
ESC 2023 — Dr Tobias Reichlin (Inselspital, University of Bern, CH) joins us on-site at ESC 2023 to discuss the findings of the COMPARE-CRYO Trial (NCT04704986).
The COMPARE-CRYO trial (Insel Gruppe AG, University Hospital Bern) aimed to compare the safety and efficacy of the PolarX Cryoballoon (Boston Scientific) with the Arctic Front Cryoballoon (Medtronic) in patients with symptomatic…
View more
Author(s):
Vincent Umbrain
,
Christian Verborgh
,
Gian-Battista Chierchia
,
et al
Added:
3 years ago
The current option for refractory treatment for atrial fibrillation (AF) includes hybrid AF-surgery.1–2 The hybrid approach was originally a combination of mini-invasive surgical epicardial evaluation and ablation, as well as endocardial electrophysiologist (EP) catheter ablation with the intention of creating a lesion set to cure AF.3 In the search for greater efficacy with less patient…
View more
Author(s):
Tom De Potter
Added:
2 years ago
In this video, Dr Tom De Potter (Cardiovascular Research Center Aalst, Aalst, BE) discusses the outcomes of the CryoCure-2 study, an open label study that was designed to examine the safety, feasibility and efficacy of ultralow temperature cryoablation in patients with paroxysmal or persistent atrial fibrillation.
Questions:
1. Please summarise the aim, study design and endpoints?
2. What were…
View more
Author(s):
Konstantinos C Siontis
,
Hakan Oral
Added:
3 years ago
Advanced catheter-based technologies employed for the ablation of symptomatic atrial fibrillation (AF) have revolutionised the management of this common sustained arrhythmia. In the late 1990s, premature depolarisations originating from the myocardial sleeves within the pulmonary veins were recognised to initiate AF. This landmark discovery rendered pulmonary vein isolation (PVI) as the…
View more
Author(s):
Geoffrey F Lewis
,
Michael R Gold
Added:
3 years ago
Since the introduction of CRT more than 20 years ago, its role in mild to severe systolic heart failure has become well established. CRT has been shown to decrease mortality, reduce heart failure hospitalisations and improve functional status in patients with NYHA class II–IV heart failure and QRS prolongation, most commonly with LBBB pattern.1 One of the major limitations of CRT implementation…
View more
Author(s):
Sanjiv M Narayan
,
Hugh Calkins
,
Andrew Grace
,
et al
Added:
1 year ago
Author(s):
Jorge E Romero
,
Ricardo Avendano
,
Michael Grushko
,
et al
Added:
3 years ago
Oesophageal injury prevention has become a major concern in the field of electrophysiology since the first case of atrio–oesophageal fistula was reported as a complication of endocardial surgical radiofrequency ablation (RFA),1 with Scanavacca et al. and Pappone et al. subsequently reporting this complication in patients who underwent percutaneous pulmonary vein isolation (PVI) for AF.2,3 It is…
View more